In Patients with Ankylosing Spondylitis Treated with Adalimumab, Combination Therapy with DMARD, Increase the Serum Level of Adalimumab and Decrease Immunogenicity
Consulta el abstract asociado a este póster
miércoles, 9
de noviembre del 2016
miércoles, 9
de noviembre del 2016
In Patients with Ankylosing Spondylitis Treated with Adalimumab, Combination Therapy with DMARD, Increase the Serum Level of Adalimumab and Decrease Immunogenicity
Consulta el póster asociado a este abstract